Senior paediatrician and key member in developing two Indian public health vaccine joins Patna AIIMS: A doctor from Bihar to Bihar

Among the best minds of India behind this success includes a doctor from Bihar Dr. Chandra Mohan.

Under 5 mortality rates in India has seen a significant improvement from 126 per 1000 live births in 1990, 83.1 in 2000 to now 36.6 per 1000 live births. In term of absolute numbers from more than 1 million deaths at the start of the Millenium to less than 5 lakhs achieved in 2018 which has further gone down very quickly. Among the most important factors achieving this are vaccinations against Rotavirus Diarrhea and Pneumonia, the top killers of under 5 children. India has achieved success in developing these important vaccines fully in India. From concept to successful clinical trials leading to licensure and WHO Prequalifications, these vaccines are Indian success stories which makes every Indian proud. Dr Chandra Mohan as Principal Investigator for Delhi site for both these vaccines was an important member of that team.

A son of a retired judge from West Champaran, Dr Chandra Mohan did his early schooling from his home-town. He has been a bright student of Netarhat Vidyalaya and Patna Science College. He studied MBBS in Calcutta National Medical College and later did MD and specialized as Pediatrician.

He has a wide range of experience working as a child specialist in Indian Railways. Because of his inbuilt inclination towards academic pursuit and research, he opted for a teaching career in medical colleges.  Over last two decades, he has served and taught Pediatrics in UP, Andhra Pradesh, Telangana, Haryana and Delhi.

After serving humanity in different roles across the nation, Dr Chandra Mohan has joined Patna AIIMS as Additional Professor, Paediatrics to serve the children of native state Bihar. We wish good luck to Dr. Chandra Mohan.

Medlarge Bureau

Recent Posts

Total 14 Patanjali products license cancelled, SC hearing scheduled for Tuesday

The Uttarakhand government has initiated major action against Baba Ramdev in light of misleading advertisements…

3 days ago

Covishield maker AstraZeneca admits Covid vaccine can cause rare side effects

For the first time post Covid period, the Covishield vaccine maker AstraZeneca has admitted that…

3 days ago

Over 50% of patients face delay in discharge due to mediclaim process: Study

A new study from healthcare provider Pristyn Care found that 5 out of 10 patients…

4 days ago

FMG students protest over 3-year internship

The Foreign Medical Students has protested against the National Medical Commission over a 3-year period…

4 days ago

World Day for Safety Health at Workplace: South-East Asia face high burden mortality

WHO South-East Asia Region (SEAR) faces a disproportionately high burden of work-related mortality, with 36.5…

5 days ago

‘Needs policy-makers intervention not model’s fake death for Cervical cancer advocacy’

Cervical cancer is a culturally sensitive disease given its transmission through the sexual route and…

5 days ago